DANCANN PHARMA A/S Financials, key figures and credit report
Gross profit -5 299.0 kDKK FY 2023 +30% vs 2022
EBIT -59 353.0 kDKK FY 2023 -270.4% vs 2022
Net debt 5 884.0 kDKK FY 2023 +328.1% vs 2022
Quick ratio 0.2 FY 2023 -1.2 vs 2022
Income statement (kDKK)
2022 | 2023 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Manufacturing for enterprise's own use | 1 481.00 | 1 080.00 |
| Other operating income | 41.00 | 923.00 |
| Purchases during the financial year | - 233.00 | - 783.00 |
| External services | -8 864.00 | -6 519.00 |
| Gross profit | -7 575.00 | -5 299.00 |
| Employee benefit expenses | -7 496.00 | -8 109.00 |
| Total depreciation | - 955.00 | -45 945.00 |
| EBIT | -16 026.00 | -59 353.00 |
| Other financial income | 1 189.00 | 203.00 |
| Other financial expenses | -3 000.00 | -2 313.00 |
| Net income from associates (fin.) | - 606.00 | - 886.00 |
| Pre-tax profit | -18 443.00 | -62 349.00 |
| Income taxes | 2 379.00 | 89.00 |
| Net earnings | -16 064.00 | -62 260.00 |
Assets (kDKK)
2022 | 2023 | |
|---|---|---|
| Development expenditure | 35 736.00 | |
| Intangible rights | 821.00 | |
| Intangible assets total | 36 557.00 | |
| Buildings | 5 936.00 | 3 839.00 |
| Advance payments and construction in progress | 3 345.00 | 97.00 |
| Tangible assets total | 9 281.00 | 3 936.00 |
| Holdings in group member companies | 12 318.00 | 11 432.00 |
| Investments total | 12 640.00 | 11 754.00 |
| Long term receivables total | ||
| Inventories total | ||
| Current amounts owed by group member comp. | 44.00 | |
| Prepayments and accrued income | 474.00 | 440.00 |
| Current other receivables | 2 352.00 | 474.00 |
| Current deferred tax assets | 1 791.00 | 216.00 |
| Short term receivables total | 4 661.00 | 1 130.00 |
| Cash and bank deposits | 10 137.00 | 890.00 |
| Cash and cash equivalents | 10 137.00 | 890.00 |
| Balance sheet total (assets) | 73 276.00 | 17 710.00 |
Equity and liabilities (kDKK)
2022 | 2023 | |
|---|---|---|
| Share capital | 2 438.00 | 5 311.00 |
| Other reserves | 27 874.00 | |
| Retained earnings | 48 545.00 | 66 455.00 |
| Profit of the financial year | -16 064.00 | -62 260.00 |
| Shareholders equity total | 62 793.00 | 9 506.00 |
| Provisions | -3.00 | |
| Non-current liabilities total | ||
| Current loans from credit institutions | 7 557.00 | 5 913.00 |
| Current trade creditors | 2 425.00 | 951.00 |
| Current owed to group member | 861.00 | |
| Other non-interest bearing current liabilities | 504.00 | 479.00 |
| Current liabilities total | 10 486.00 | 8 204.00 |
| Balance sheet total (liabilities) | 73 276.00 | 17 710.00 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated